Hydrostasis aims to be the standard of care in hydration monitoring. 75% of adults in the US are chronically dehydrated, costing $20B annually and leading to chronic conditions such as diabetes, kidney disease, and dementia. Consumer device manufacturers are looking for better health insights, and clinicians need objective data and remote patient monitoring. Using patented sensor design and proprietary algorithms, the Hydrostasis solution is non-invasive, cross-platform, and device-agnostic. Hydrostasis is supported by SOSV, NIH, the and the US Air Force, and has planned clinical validation studies at UCSD, NYU, and Azalee Care (Japan).